GenBioPro

GenBioPro is a United States pharmaceutical company which makes and distributes a generic version of the medication abortion drug mifepristone.

History

In 2019 GenBioPro obtained Food and Drug Administration authorization to sell a generic version of mifepristone. Despite the FDA saying that it tries to approve generic drug applications in 10 months, this application was approved after 10 years.
In 2023, GenBioPro sued the FDA to obtain a legal judgement confirming that mifepristone could continue to be sold, in spite of anti-abortion laws passed in some states.